Yu-ra Choi
Targeted Therapy Branch, Goyang 10408
Goyang, Republic of Korea
Goyang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
EI24 suppresses TNBC tumorigenesis by regulating AKT signaling.
Journal: Frontiers in oncology
Published: May 18, 2026
Overcoming MET-targeted drug resistance in MET-amplified lung cancer by aurora kinase B inhibition.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: January 22, 2025
Detailed characterization of combination treatment with MET inhibitor plus EGFR inhibitor in EGFR-mutant and MET-amplified non-small cell lung cancer.
Journal: Translational lung cancer research
Published: March 25, 2024
Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer.
Journal: British journal of cancer
Published: October 17, 2022
Structural and rheological properties of pectic polysaccharide extracted from Ulmus davidiana esterified by succinic acid.
Journal: International journal of biological macromolecules
Published: May 29, 2018
The characterization, selenylation and anti-inflammatory activity of pectic polysaccharides extracted from Ulmus pumila L.
Journal: International journal of biological macromolecules
Published: November 15, 2017
Reduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cells.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 02, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026